Weight problems Drug Demand Outstrips Provide

Eli Lilly’s blockbuster diabetes treatment Mounjaro is anticipated to obtain Meals and Drug Administration approval as an weight problems remedy earlier than the top of the yr, which might result in a surge in demand. Whether or not there will likely be sufficient of the drug is a special query. 

Each Lilly and its competitor, Denmark’s Novo Nordisk, which makes Ozempic and its sister drug Wegovy, are struggling to fulfill skyrocketing demand for his or her drugs. There isn’t a fast repair for that given the complexity of constructing out manufacturing capability for the injections. Each corporations are investing billions of {dollars} a yr to attempt to catch up.